The French scientists concluded, “This study supports the use of immunomodulatory drugs such as ivermectin, to improve the clinical condition of SARS-CoV-infected patients.”
Altogether, this study brings the proof of concept that an IVM-based immunomodulatory therapy improves the clinical condition of SARS-CoV-2-infected hamsters, and in clinical trials, it alleviates symptoms of COVID-19 in humans and possibly limits post-COVID-19 syndrome (also known as long COVID) via an anti-inflammatory action.
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
Over 10,000 patients,a fatality rate more than 97% LOWER than France’s – an exceptional case for early treatment with a drug regimen including HCQ & AZM.
“The Minister of Health, Marcelo Queiroga, has announced that he will soon launch a protocol of drugs to be used in the treatment against Covid-19. ”
This guide, which should guide health workers, has, as likely drugs, hydroxychloroquine and ivermectin.
It is high time to open our eyes, to hold our governments to account, and to fundamentally reform a system that has been misled by the interests of the all-powerful pharmaceutical industry. ”
Source: The New American Author: Annalisa Pesek Calls are increasing for investigations into Dr. Anthony Fauci’s intentional suppression of inexpensive and easily accessible, life-saving treatments for COVID-19.
India has conquered the disease with hydroxychloroquine and ivermectin, uses a traditional vaccine, exports experimental vaccines for these idiotic Westerners … There are 1,230 deaths per million inhabitants over 65 (six times less than in France). If we had listened to Raoult and followed the Indian model, today we would have 500 cases of covid per day and 75,000 fewer deaths …
Early treatment intervention with hydoxychloroquine & Ivermectin appears to have played a major role in control in India, precipitating local herd immunity.
The recourse to the treatment with hydroxychloroquine advocated by Professor Raoult would have made it possible to greatly reduce the number of deaths and to avoid the appalling present situation.
Ivermectin: There is a technique of discrediting which is all the rage, always to manipulate: to criticize the form, to make forget the main one: the result. Virtually all of the studies cited by the paper are 95% criticized on form and not on substance, leading to the conclusion, despite results that even a 5-year-old would find obvious, that there is insufficient evidence. If, one day, public domain Ivermectin becomes THE drug against Sars-Cov-2, that will result in billions of losses for the global pharmaceutical industry.
With such a rate of contamination, we are faced with a scenario of collective quasi-immunity managed with a broad prescription of early and prophylactic treatment based on hydroxychloroquine. With a contamination rate of 56%, mortality is 549 people per million inhabitants. Last December, the Institut Pasteur estimated the rate of the French population to be contaminated at 11.3% [1]. Mortality in France is 1200 [2] people per million inhabitants. The population of Delhi is five times more contaminated with mortality more than two times lower compared to France. The case fatality rate with early treatment in Delhi, which is 0.1%, is close to the rate estimated by Professor Raoult in the case of early treatment.
No cases of sudden death were observed. From publication, we have treated 3,119 patients with HCQ-AZ for at least three days.
While Professor Raoult was testing, isolating and treating his patients, the government decided to send the patients home, without care and with Doliprane for only treatment!
The health bureaucrats have violated the first principle of the Hippocratic Oath , which is to do no harm.
Hydroxychloroquine will now be on sale in pharmaceutical pharmacies in france, as part of the treatment for COVID-19
medical service for remdesivir is weak and that access to reimbursement is not justified to treat the most severe forms of the disease.
We believe this study is fatally flawed: “Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis”.
A Belgian study has just been published, on 8,000 patients, and concludes that hydroxychloroquine reduces mortality by 30%
Indeed, following bivariate analysis, hydroxychloroquine/azithromycin treatment was associated with a lower rate of ICU admission (P=0.008).
Source: Sante Cool PROFESSOR PERRONNE DISCOVERS THE SAME RESULTS FROM HYDROXYCHLOROQUINE AS DIDIER RAOULT. HERE IS THE STUDY AND THE RESULTS. The Pr Perronne discovers the same results
Indeed, our study suggests that AZI±HCQ might have impacted COVID-19 outcome in a population of patients, optimal timing of treatment interventions to study
Patients in the Recovery Trial immediately receive 800 milligrams of hydroxychloroquine sulfate, yet the advised dosage is less than 500 mg for an adult man of average height
FranceSoir’s team have done some more excellent work in cutting through the dearth and making sense of some conflicting information. Source: FranceSoir Authors: Michel Jullian and
“But there are a lot of studies that have shown that the benefits have not received as much attention, not just our study. “
Source: Science Direct Background In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment
Source: LeMonde France The controversial infectious disease specialist was interviewed Wednesday by the National Assembly’s commission of inquiry into the coronavirus. After the masks, which were
In order to insert an HIV sequence into this genome, molecular tools are needed, and that can only be done in a laboratory.
This represents a 25% relative increase in the likelihood of being discharged from hospital, the study said.
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
Source: Preprints.org The challenge regarding COVID-19 is to prevent complications and fatal evolution. Azithromycin (AZM) and hydroxychloroquine (HCQ) have proven their antiviral effect in vitro.
Source: Mediterranee Infection COVID-IHU #15 Version 1 du 27 Mai 2020Early diagnosis and management of COVID-19 patients: a real-life cohort study of 3,737 patients, Marseille, France Abstract Background:In our institute in Marseille, France, we
Source: Mediterranee Infection Why this discrepancy between the preprint version and the version published in the BMJ? Tang et al. – Data (text and figures) evidencing
Source: MedRxiv Repurposed drugs that are immediately available and have a good safety profile constitute a first line of defence against new viral infections. Despite
Source: Science Direct Abstract Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is used in the treatment of COVID-19. Methods We retrospectively report
TRANSLATED: ZINFOS974 The request to the State Council of Me Krikorian gave rise to an order made this Wednesday, April 22, which, in its reasons,
Response to Magagnoli, MedRxiv, 2020 Matthieu MILLION1,2, Yanis ROUSSEL1,2, Didier RAOULT1,2 1 IHU-Méditerranée Infection, Marseille, France 2 Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France
Given the speed of evolution of the epidemic and the permanent information needs of the scientific community, combined with the difficulty of travel, the IHU
Professor Didier Raoult has reserved for the President of the Republic the exclusivity of his follow-up study on 1,061 patients passed through his services. Virologic healing
Source: TechStartUps As coronavirus death toll continues to rise around the world, there is a growing call for the use of use of hydroxychloroquine for treatment of
